Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
Author:
Funder
National Institutes of Health, USA
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference47 articles.
1. Antiandrogens inhibit ABCB1 efflux and ATPase activity and reverse docetaxel resistance in advanced prostate cancer;Zhu;Clin. Canc. Res.,2015
2. Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies;Armstrong;Am. J. Clin. Exp. Urol.,2015
3. Overcoming docetaxel resistance in prostate cancer: a perspective review;Hwang;Ther. Adv. Med. Oncol.,2012
4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N. Engl. J. Med.,2004
5. Frequent down-regulation of ABC transporter genes in prostate cancer;Demidenko;BMC Canc.,2015
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advancement in Mechanistic Alteration of IGFs Family of Receptors to Target Prostate and Cervical Cancer: An Updated Review;Current Cancer Therapy Reviews;2024-08-19
2. A cross‐species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk;The Prostate;2024-08-07
3. The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens;Biomedicines;2024-07-23
4. Resveratrol-based nano-formulations as an emerging therapeutic strategy for ovarian carcinoma: autophagy stimulation and SIRT-1/Beclin/MMP-9/P53/AKT signaling;Cancer Nanotechnology;2024-07-15
5. The small phytomolecule resveratrol: A promising role in boosting tumor cell chemosensitivity;Pharmacia;2024-06-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3